In the early stages of CKD, patients may not have many signs or symptoms, impacting the diagnosis and management of the disease. CKD may not become apparent until kidney function is significantly impaired. However, there are certain signs that people with diabetes may be developing CKD that can...
However, systematic testing might become decisive to improve the care response even in the case of chronic pathologies and, in this review, we analyzed the state-of-the-art of the POC diagnostics for Chronic Kidney Disease, Chronic Obstructive Pulmonary Disease and Multiple Sclerosis. The different...
Laboratory Testing for Chronic Kidney Disease Diagnosis and Management. In addition, the Kidney Failure Risk equation (KidneyFailureRisk.com) uses ACR and eGFR to estimate the risk of persons developing CKD and progressing to ESRD. How the laboratory can help Quest Diagnostics...
Although chronic kidney disease (CKD) shares several risk factors with the non-communicable diseases (NCDs) recognized by the WHO as major drivers of premature mortality — heart disease, stroke, cancer, diabetes and chronic lung disease — several other major causes of CKD, including acute kidney...
Abstract Worldwide, chronic kidney disease (CKD) is a systemic healthcare burden, necessitating continuous innovation in diagnostic and therapeutic strategies. Henceforth, many research endeavors have been pursued to develop point-of-care (POC) technologies aimed at recognizing CKD biomarkers. This resear...
proteinuria, prior kidney surgery, hypertension, gout, or diabetes mellitus.5,24,25Serum creatinine can be used to determine the estimated glomerular filtration rate (eGFR) of the patient with the modification of diet in renal disease (MDRD) equation that is currently in wide use in many laborat...
Chronic kidney disease (CKD) has been associated with a higher risk of cardiovascular disease (CVD). CKD patients present a decrease in the levels of the protein Klotho that accompanies the decrease in kidney function. This protein has been related to protective effects against CVD. However, it...
Carboxypeptidase B1 has long been known to be a pancreas-specific tissue enzyme. In this paper we focus on Carboxypeptidase B1 concentration measurement in dialyzed chronic kidney kidney disease patients and on the effect dialysis adequacy and regimen ex
chronic kidney disease diagnostics -Urinalysis, proteinuria, hematuria-x-ray-CT or ultrasound (avoid contrast)-creatinine clearance metabolic changes -BUN and C is altered (buildup of nitrogenous waste)-uremia-hyponatremia or hypernatremia may occur-hyperkalemia (can get up to 8)-metabolic acidosis ...
1).5,55 The accuracy of these data is not known, however, because in many places in sub-Saharan Africa the access to diagnosis of kidney disease (awareness among health care workers, availability of diagnostics tests) remains low, and it is possible that the actual numbers are significantly ...